Heron Therapeutics, Inc.
HRTX· Nasdaq
HRTXHeron Therapeutics, Inc.
Filed Aug 8, 2013 · 10-Q · 39 days after period end · 0001193125-13-325343
| Metric | Q2 2013 | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|---|
| Net Income | -$15.41M | -$4.57M | -$1.93M | -$3.58M |
| EPS Diluted | -$1.01 | -$0.46 | -$0.05 | -$0.09 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Heron Therapeutics, Inc. · CIK 818033 · Engraved from SEC EDGAR
ended Jun 30, 2013 · filed Aug 8, 2013 · 39 d after period end
